| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7ddc4774cf5f8a0bda44a780d73c53d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7254887bc4324c447a6a7cfda1e6b29c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
2008-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0aa1f6042925d4758a0d3e337792a8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_680f685f52b2b42be36e33521a955736
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c8df846b415ea683b2a71bfd730dab3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ed593080ced9708ab71c194274ab85f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_406ca3fdfa6806c93073d9752ffd7e0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcb500e9166a392ef332df1f7b54e1e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c3d05da14733b821679467328b0bdca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f7eb501cb07a99f6eb55067c5527802
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6df1d28edfb76009b4fd42350400e615 |
| publicationDate |
2015-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-PI0820494-A8 |
| titleOfInvention |
METHODS FOR PREPARING CAPECITABIN AND BETA-ANOMER RICH TRIALKYL CARBONATE COMPOUND USED IN THE SAME |
| abstract |
METHODS FOR PREPARING CAPECITABIN AND BETA-ANOMER RICH TRIALKYL CARBONATE COMPOUND USED THEREOF. The present invention relates to a method of preparing capecitabine and a method of preparing a B-anomer-rich trialkyl carbonate compound used herein, and a highly pure capecitabine can be efficiently prepared in high yield by the method of the present invention using the B-anomer rich trialkyl carbonate compound as an intermediate. |
| priorityDate |
2007-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |